Company Filing History:
Years Active: 2014-2023
Title: Karl J M Hanf: Innovator in Antibody Development
Introduction
Karl J M Hanf is a notable inventor based in Billerica, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 2 patents, his work has the potential to impact various medical treatments.
Latest Patents
Hanf's latest patents include "Anti-transferrin receptor antibodies and uses thereof." This patent provides anti-transferrin receptor antibodies, compositions comprising the same, and methods of their use. It also includes polynucleotides and vectors encoding the antibodies, as well as methods for making them. Another significant patent is "Anti-CD154 antibodies," which offers peptides and antibodies that include at least one amino acid substitution compared to the wild type 5c8 antibody. This invention also provides methods for treating CD154-related diseases or disorders.
Career Highlights
Throughout his career, Hanf has worked with prominent companies in the biotechnology sector, including Biogen Idec MA Inc. and Biogen MA Inc. His experience in these organizations has allowed him to develop and refine his expertise in antibody research and development.
Collaborations
Hanf has collaborated with notable professionals in the field, including Herman Van Vlijmen and Alexey Alexandrovic Lugovskoy. These collaborations have likely contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Karl J M Hanf is a distinguished inventor whose work in antibody development has the potential to lead to significant advancements in medical treatments. His contributions to the field are marked by his innovative patents and collaborations with other experts.